MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Marketable securities$205,304K Cash and cashequivalents$90,394K Prepaid expenses andother current assets$8,719K Collaboration receivable$1,177K Restricted cash, currentportion$658K Total current assets$306,252K Right-of-use assets,operating leases$60,451K Property and equipment,net$7,313K Restricted cash, net ofcurrent portion$3,292K Other non-currentassets$70K Total assets$377,378K Total liabilities andstockholders equity$377,378K Total stockholdersequity$306,133K Total liabilities$71,245K Accumulated deficit-$273,094K Additional paidin capital$578,571K Operating leaseobligations, net of current...$46,794K Total currentliabilities$24,451K Accumulated othercomprehensive income (loss)$652K Common stock, par value0.0001 150,000,000...$4K Accrued expenses andother current...$17,682K Operating leaseobligations, current portion$4,138K Accounts payable$2,289K Deferred revenue,current portion$342K
Balance Sheet
source: myfinsight.com

Entrada Therapeutics, Inc. (TRDA)

Entrada Therapeutics, Inc. (TRDA)